These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 12866304)

  • 21. [Clearly superior in acute coronary syndrome. Helps aggressive platelet inhibition even after stroke?].
    MMW Fortschr Med; 2003 Mar; 145(10):57. PubMed ID: 12688032
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
    Weintraub WS; Mahoney EM; Lamy A; Culler S; Yuan Y; Caro J; Gabriel S; Yusuf S;
    J Am Coll Cardiol; 2005 Mar; 45(6):838-45. PubMed ID: 15766816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trial.
    Ringborg A; Lindgren P; Jönsson B
    Eur J Health Econ; 2005 Dec; 6(4):354-6, 358-62. PubMed ID: 16267654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute coronary syndrome: when an indication for clopidogrel?].
    Köster R
    Dtsch Med Wochenschr; 2006 Dec; 131(50):2864. PubMed ID: 17160771
    [No Abstract]   [Full Text] [Related]  

  • 27. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
    Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Beinart SC; Kolm P; Veledar E; Zhang Z; Mahoney EM; Bouin O; Gabriel S; Jackson J; Chen R; Caro J; Steinhubl S; Topol E; Weintraub WS
    J Am Coll Cardiol; 2005 Sep; 46(5):761-9. PubMed ID: 16139122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Merella P; Casu G; Meloni I
    N Engl J Med; 2010 Dec; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
    [No Abstract]   [Full Text] [Related]  

  • 31. Clopidogrel and the CURE results.
    Maggioni AP
    Haematologica; 2001 Nov; 86(11 Suppl 2):40. PubMed ID: 11926775
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute heart attacks. Prognosis can be further improved].
    Einecke D
    MMW Fortschr Med; 2001 Apr; 143(14):4-5. PubMed ID: 11340908
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J
    Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
    Mahoney EM; Mehta S; Yuan Y; Jackson J; Chen R; Gabriel S; Lamy A; Culler S; Caro J; Yusuf S; Weintraub WS;
    Am Heart J; 2006 Jan; 151(1):219-27. PubMed ID: 16368322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 36. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

  • 37. Translational therapeutics at the platelet vascular interface. Summary.
    FitzGerald GA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
    [No Abstract]   [Full Text] [Related]  

  • 38. Plavix isn't for everyone. Adding Plavix to aspirin doesn't help people without heart disease.
    Harv Heart Lett; 2006 Jun; 16(10):1. PubMed ID: 16791939
    [No Abstract]   [Full Text] [Related]  

  • 39. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
    Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.